Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 31.66% Profit: A Win for QuantWave

May 03, 2023
ELI LILLY AND COMPANY, a leading pharmaceutical company, saw its stock reach the forecasted price target with an impressive profit of 31.66%. The forecast signal date of February 21, 2023, indicated a long position at a price of 321.33 $. Fast forward to May 3, 2023, the stock exceeded expectations by reaching 423.05 $, delivering substantial gains to investors who followed the prediction from QuantWave.

This success showcases the accuracy and effectiveness of QuantWave's forecasting capabilities. By leveraging advanced algorithms and data analytics, QuantWave was able to provide a precise prediction for ELI LILLY AND COMPANY's stock movement. The achievement of the forecasted price target further solidifies QuantWave's position as a reliable automated forecasting platform for investors seeking profitable opportunities in the market.

Several factors may have contributed to the stock's movement in line with the forecast. ELI LILLY AND COMPANY's strong financial performance, positive industry trends, and overall market sentiment could have played a role in driving the stock price towards the predicted target. Additionally, macroeconomic factors and sector-specific developments may have influenced investor behavior and contributed to the successful outcome of the forecast.

For investors looking to capitalize on accurate predictions and potential profits, QuantWave offers a diverse range of stock forecasts to help navigate the complex financial markets. With a track record of delivering reliable forecasts and profitable outcomes, QuantWave presents valuable opportunities for investors to optimize their investment strategies and achieve their financial goals.

In conclusion, the achievement of the price target forecast for ELI LILLY AND COMPANY represents a significant win for QuantWave and its users. As an innovative forecasting platform, QuantWave continues to demonstrate its ability to generate actionable insights and profitable opportunities in the financial markets. For those interested in exploring the power of QuantWave's forecasting system further, QuantSchool provides comprehensive educational resources and investment frameworks to unlock the full potential of the platform.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 21.51% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profitable outcome for investors....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast on QuantWave with 16.34% Profit  ~2 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. with a price target forecast of 571.74 $, signaling a potential 16....


REGNOctober 31, 2024REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Price Target with Profit of 17.54%  ~2 min.

REGENERON PHARMACEUTICALS, INC. (stock ticker: REGN) recently saw its stock price hit the forecast target set by QuantWave, a leading automated forecasting platform....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INC Hits QuantWave Price Target with 14.91% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 14.91%....


AVAX-USDMarch 9, 2025QuantWave Achieves 47.61% Profit Target Forecast for AVALANCHE USD  ~1 min.

QuantWave, the automated forecasting platform, has successfully predicted a price target for the stock AVALANCHE USD, yielding a profit of 47.61%....